The research time span covered by the report is from 2019 to 2030; it provides an overview of the Global Botulinum Toxin Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Botulinum Toxin market size in 2023 is 6612.4 million US dollars, and it is expected to be 11629.6 million US dollars by 2030, with a compound annual growth rate of 8.4% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Botulinum Toxin market include Ipsen Pharma, AbbVie Inc., Medy-Tox, Inc., Merz Pharma, and US Worldmeds. The share of the top 3 players in the Botulinum Toxin market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Botulinum Toxin market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Type A accounted for XX% of Botulinum Toxin market in 2023. Type B share of XX%.
Aesthetic accounted for XX% of the Botulinum Toxin market in 2023. Therapeutic accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it”s going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, study objectives, and industry dynamic analysis, and then includes the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Botulinum Toxin market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players” M&A and expansion in recent years.
Chapters 3-6: Segmented the global Botulinum Toxin market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 7: Analyzes the main companies in the Botulinum Toxin industry, including their main businesses, products/services, sales, revenue, gross margin, and the latest developments.
Chapter 8: Analyzes the Botulinum Toxin industry chain, including raw material analysis, sales and marketing, distributors and major downstream buyers.
Chapter 9: The main points and conclusions of the report.
Chapter 10: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Player list
Ipsen Pharma
AbbVie Inc.
Medy-Tox, Inc.
Merz Pharma
US Worldmeds
Evolus, Inc.
Galderma
Metabiologics Inc.
Lanzhou Institute of Biological Products co.
Tenjin Pharma
Eisai Co., Ltd.
Anika Therapeutics, Inc.
Hugh Source International Ltd
Types list
Type A
Type B
Application list
Aesthetic
Therapeutic
Table of Content
1 Study Coverage
1.1 Botulinum Toxin Product Introduction
1.2 Global Botulinum Toxin Outlook 2019 VS 2024 VS 2030
1.3 United States Botulinum Toxin Outlook 2019 VS 2024 VS 2030
1.4 Botulinum Toxin Market Size, United States VS Global, 2019-2030
1.4.1 The Market Share of United States Botulinum Toxin in Global, 2019-2030
1.4.2 The Growth Rate of Botulinum Toxin Market Size, United States VS Global, 2019 VS 2024 VS 2030
1.5 Botulinum Toxin Market Dynamics
1.5.1 Botulinum Toxin Market Trends
1.5.2 Botulinum Toxin Market Drivers
1.5.3 Botulinum Toxin Market Challenges
1.5.4 Botulinum Toxin Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Botulinum Toxin Competitor Landscape by Company
2.1 Global Botulinum Toxin Market Size by Company
2.1.1 Top Global Botulinum Toxin Player Ranked by Revenue (2024)
2.1.2 Global Botulinum Toxin Revenue by Player (2019-2024)
2.2 Global Botulinum Toxin Concentration Ratio (CR)
2.2.1 Botulinum Toxin Market Concentration Ratio (CR) (2019-2024)
2.2.2 Global Top 3 and Top 6 Largest Players of Botulinum Toxin in 2024
2.3 Global Botulinum Toxin Business Distribution, Business Type
2.3.1 Global Botulinum Toxin Players, Headquarters and Distribution
2.3.2 Players Botulinum Toxin Business Type
2.3.3 Date of International Players Enter into Botulinum Toxin Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Botulinum Toxin Market Size by Company
2.5.1 Top United States Botulinum Toxin Player s Ranked by Revenue (2024)
2.5.2 United States Botulinum Toxin Revenue by Player (2019-2024)
3 Botulinum Toxin Market Segment by Type
3.1 Botulinum Toxin Market Segment by Type
3.2 Global Botulinum Toxin Market Size by Type
3.3 United States Botulinum Toxin Market Size by Type
4 Botulinum Toxin Market Segment by Application
4.1 Botulinum Toxin Market Segment by Application
4.2 Global Botulinum Toxin Market Size by Application
4.3 United States Botulinum Toxin Market Size by Application
5 Global Botulinum Toxin Market Size by Region
5.1 Global Botulinum Toxin Market Size by Region: 2019 VS 2024 VS 2030
5.2 Global Botulinum Toxin Market Size in Value by Region (2019-2030)
5.2.1 Global Botulinum Toxin Revenue by Region: 2019-2024
5.2.2 Global Botulinum Toxin Revenue by Region: 2024-2030
5.3 Global Botulinum Toxin Market Size in Volume by Region (2019-2030)
5.3.1 Global Botulinum Toxin Volume by Region: 2019-2024
5.3.2 Global Botulinum Toxin Volume by Region: 2024-2030
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Botulinum Toxin Market Size YoY Growth 2019-2030
6.1.2 North America Botulinum Toxin Market Facts & Figures by Country (2019-2030)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Botulinum Toxin Market Size YoY Growth 2019-2030
6.2.2 Asia Pacific Botulinum Toxin Market Facts & Figures by Country (2019-2030)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Botulinum Toxin Market Size YoY Growth 2019-2030
6.3.2 Europe Botulinum Toxin Market Facts & Figures by Country (2019-2030)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Botulinum Toxin Market Size YoY Growth 2019-2030
6.4.2 Latin America Botulinum Toxin Market Facts & Figures by Country (2019-2030)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Botulinum Toxin Market Size YoY Growth 2019-2030
6.5.2 Middle East and Africa Botulinum Toxin Market Facts & Figures by Country (2019-2030)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Ipsen Pharma
7.1.1 Ipsen Pharma Company Details
7.1.2 Description and Business Overview
7.1.3 Botulinum Toxin Introduction
7.1.4 Ipsen Pharma Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.1.5 Ipsen Pharma Recent Development
7.2 AbbVie Inc.
7.2.1 AbbVie Inc. Company Details
7.2.2 Description and Business Overview
7.2.3 Botulinum Toxin Introduction
7.2.4 AbbVie Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.2.5 AbbVie Inc. Recent Development
7.3 Medy-Tox, Inc.
7.3.1 Medy-Tox, Inc. Company Details
7.3.2 Description and Business Overview
7.3.3 Botulinum Toxin Introduction
7.3.4 Medy-Tox, Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.3.5 Medy-Tox, Inc. Recent Development
7.4 Merz Pharma
7.4.1 Merz Pharma Company Details
7.4.2 Description and Business Overview
7.4.3 Botulinum Toxin Introduction
7.4.4 Merz Pharma Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.4.5 Merz Pharma Recent Development
7.5 US Worldmeds
7.5.1 US Worldmeds Company Details
7.5.2 Description and Business Overview
7.5.3 Botulinum Toxin Introduction
7.5.4 US Worldmeds Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.5.5 US Worldmeds Recent Development
7.6 Evolus, Inc.
7.6.1 Evolus, Inc. Company Details
7.6.2 Description and Business Overview
7.6.3 Botulinum Toxin Introduction
7.6.4 Evolus, Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.6.5 Evolus, Inc. Recent Development
7.7 Galderma
7.7.1 Galderma Company Details
7.7.2 Description and Business Overview
7.7.3 Botulinum Toxin Introduction
7.7.4 Galderma Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.7.5 Galderma Recent Development
7.8 Metabiologics Inc.
7.8.1 Metabiologics Inc. Company Details
7.8.2 Description and Business Overview
7.8.3 Botulinum Toxin Introduction
7.8.4 Metabiologics Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.8.5 Metabiologics Inc. Recent Development
7.9 Lanzhou Institute of Biological Products co.
7.9.1 Lanzhou Institute of Biological Products co. Company Details
7.9.2 Description and Business Overview
7.9.3 Botulinum Toxin Introduction
7.9.4 Lanzhou Institute of Biological Products co. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.9.5 Lanzhou Institute of Biological Products co. Recent Development
7.10 Tenjin Pharma
7.10.1 Tenjin Pharma Company Details
7.10.2 Description and Business Overview
7.10.3 Botulinum Toxin Introduction
7.10.4 Tenjin Pharma Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.10.5 Tenjin Pharma Recent Development
7.11 Eisai Co., Ltd.
7.11.1 Eisai Co., Ltd. Company Details
7.11.2 Description and Business Overview
7.11.3 Botulinum Toxin Introduction
7.11.4 Eisai Co., Ltd. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.11.5 Eisai Co., Ltd. Recent Development
7.12 Anika Therapeutics, Inc.
7.12.1 Anika Therapeutics, Inc. Company Details
7.12.2 Description and Business Overview
7.12.3 Botulinum Toxin Introduction
7.12.4 Anika Therapeutics, Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.12.5 Anika Therapeutics, Inc. Recent Development
7.13 Hugh Source International Ltd
7.13.1 Hugh Source International Ltd Company Details
7.13.2 Description and Business Overview
7.13.3 Botulinum Toxin Introduction
7.13.4 Hugh Source International Ltd Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024)
7.13.5 Hugh Source International Ltd Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Botulinum Toxin Value Chain Analysis
8.2 Botulinum Toxin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Distributors List
8.3 Botulinum Toxin Production Mode & Process
8.4 Botulinum Toxin Sales and Marketing
8.4.1 Magnetic Coupled Mixers Sales Channels
8.4.2 Magnetic Coupled Mixers Distributors
8.5 Magnetic Coupled Mixers Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 A Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 B Data Source
10.2.1 Legal Disclaimer
List of Tables and Figures
Figure Botulinum Toxin Product Picture
Table Global Botulinum Toxin Revenue, ($), 2019 VS 2024 VS 2030
Figure Global Botulinum Toxin Market Size 2019-2030 ($)
Table United States Botulinum Toxin Revenue, ($), 2019 VS 2024 VS 2030
Figure United States Botulinum Toxin Market Size 2019-2030 ($)
Figure United States Botulinum Toxin Market Share in Global, in Value 2019-2030
Table Botulinum Toxin CAGR in Value, United States VS Global, 2019 VS 2024 VS 2030
Table Botulinum Toxin Market Trends
Table Botulinum Toxin Market Drivers
Table Botulinum Toxin Market Challenges
Table Botulinum Toxin Market Restraints
Figure Botulinum Toxin Report Years Considered
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Top Botulinum Toxin Players in Global Market, Ranking by Revenue (2024)
Table Global Botulinum Toxin Revenue by Player, ($), 2019-2024
Table Global Botulinum Toxin Revenue Share by Player, 2019-2024
Table Global Botulinum Toxin Players Market Concentration Ratio (CR5)
Figure The Top 3 and 6 Largest Players of Botulinum Toxin in the World: Market Share by Botulinum Toxin Revenue in 2024
Table Top Players of Botulinum Toxin in Global Market, Headquarters and Distribution
Table Players Botulinum Toxin Business Type
Table Date of International Players Enter into Botulinum Toxin Market
Table Players Mergers & Acquisitions, Expansion Plans
Table Top Botulinum Toxin Players in United States Market, Ranking by Revenue (2024)
Table United States Botulinum Toxin Revenue by Player, ($), 2019-2024
Table United States Botulinum Toxin Revenue Share by Player, 2019-2024
Table Global Botulinum Toxin Revenue by Type: 2024 VS 2030 ($)
Figure Global Botulinum Toxin Market Share by Type in 2024 & 2030
Figure Global Botulinum Toxin Revenue by Type (2019-2030) & ($)
Figure Global Botulinum Toxin Revenue Market Share in Value by Type (2019-2030)
Table United States Botulinum Toxin Revenue by Type: 2024 VS 2030 ($)
Figure United States Botulinum Toxin Market Share by Type in 2024 & 2030
Figure United States Botulinum Toxin Revenue by Type (2019-2030) & ($)
Figure United States Botulinum Toxin Revenue Market Share in Value by Type (2019-2030)
Table Global Botulinum Toxin Revenue by Application: 2024 VS 2030 ($)
Figure Global Botulinum Toxin Market Share by Application in 2024 & 2030
Figure Global Botulinum Toxin Revenue by Application (2019-2030) & ($)
Figure Global Botulinum Toxin Revenue Market Share in Value by Application (2019-2030)
Table United States Botulinum Toxin Revenue by Application: 2024 VS 2030 ($)
Figure United States Botulinum Toxin Market Share by Application in 2024 & 2030
Figure United States Botulinum Toxin Revenue by Application (2019-2030) & ($)
Figure United States Botulinum Toxin Revenue Market Share in Value by Application (2019-2030)
Table Global Botulinum Toxin Market Size by Region ($): 2019 VS 2024 VS 2030
Figure Global Botulinum Toxin Market Size Market Share by Region: 2019 VS 2024 VS 2030
Table Global Botulinum Toxin Revenue by Region (2019-2024) & ($)
Table Global Botulinum Toxin Revenue Forecast by Region (2024-2030) & ($)
Table Global Botulinum Toxin Revenue Market Share by Region (2019-2030)
Table Global Botulinum Toxin Volume by Region (2019-2024) & ($)
Table Global Botulinum Toxin Volume Forecast by Region (2024-2030) & ($)
Table Global Botulinum Toxin Volume Market Share by Region (2019-2030)
Figure North America Botulinum Toxin Revenue Growth Rate 2019-2030
Table North America Botulinum Toxin Revenue by Country (2019-2030) & ($)
Figure U.S. Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Canada Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Asia Pacific Botulinum Toxin Revenue Growth Rate 2019-2030 ($)
Table Asia Pacific Botulinum Toxin Revenue by Country (2019-2030) & ($)
Figure China Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Japan Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure South Korea Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure India Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Australia Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Southeast Asia Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Europe Botulinum Toxin Revenue Growth Rate 2019-2030 ($)
Table Europe Botulinum Toxin Revenue by Country (2019-2030) & ($)
Figure Germany Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure France Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure UK Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Italy Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Russia Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Latin America Botulinum Toxin Revenue Growth Rate 2019-2030 ($)
Table Latin America Botulinum Toxin Revenue by Country (2019-2030) & ($)
Figure Mexico Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Brazil Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Argentina Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Middle East and Africa Botulinum Toxin Revenue Growth Rate 2019-2030 ($)
Table Middle East and Africa Botulinum Toxin Revenue by Country (2019-2030) & ($)
Figure Turkey Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure Saudi Arabia Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Figure UAE Botulinum Toxin Revenue Growth Rate (2019-2030) & ($)
Table Ipsen Pharma Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Ipsen Pharma Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Ipsen Pharma Recent Development
Table AbbVie Inc. Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table AbbVie Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table AbbVie Inc. Recent Development
Table Medy-Tox, Inc. Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Medy-Tox, Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Medy-Tox, Inc. Recent Development
Table Merz Pharma Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Merz Pharma Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Merz Pharma Recent Development
Table US Worldmeds Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table US Worldmeds Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table US Worldmeds Recent Development
Table Evolus, Inc. Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Evolus, Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Evolus, Inc. Recent Development
Table Galderma Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Galderma Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Galderma Recent Development
Table Metabiologics Inc. Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Metabiologics Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Metabiologics Inc. Recent Development
Table Lanzhou Institute of Biological Products co. Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Lanzhou Institute of Biological Products co. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Lanzhou Institute of Biological Products co. Recent Development
Table Tenjin Pharma Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Tenjin Pharma Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Tenjin Pharma Recent Development
Table Eisai Co., Ltd. Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Eisai Co., Ltd. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Eisai Co., Ltd. Recent Development
Table Anika Therapeutics, Inc. Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Anika Therapeutics, Inc. Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Anika Therapeutics, Inc. Recent Development
Table Hugh Source International Ltd Company Details
Table Description and Business Overview
Table Botulinum Toxin Introduction
Table Hugh Source International Ltd Botulinum Toxin Revenue, Sales, and Gross Margin (2019-2024) (Million USD)
Table Hugh Source International Ltd Recent Development
Figure Botulinum Toxin Value Chain
Table Key Raw Materials
Table Major Distributors of Botulinum Toxin with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report